Letko, Brosseau & Associates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.3M | Buy |
918,190
+21,765
| +2% | +$600K | 0.48% | 55 |
|
|
2025
Q1 | $25.4M | Sell |
896,425
-26,920
| -3% | -$763K | 0.54% | 53 |
|
|
2024
Q4 | $38.4M | Buy |
923,345
+412,200
| +81% | +$17.1M | 0.74% | 52 |
|
|
2024
Q3 | $34.2M | Buy |
511,145
+195,745
| +62% | +$13.1M | 0.62% | 53 |
|
|
2024
Q2 | $37.5M | Sell |
315,400
-4,650
| -1% | -$552K | 0.71% | 50 |
|
|
2024
Q1 | $34.1M | Buy |
320,050
+620
| +0.2% | +$66.1K | 0.59% | 57 |
|
|
2023
Q4 | $31.8M | Buy |
+319,430
| New | +$31.8M | 0.58% | 57 |
|